Synthesis, Characterization, In-Vitro and In-Vivo Evaluation of Ketorolac Tromethamine-Loaded Hydrogels of Glutamic Acid as Controlled Release Carrier.

drug release hydrogels in-vivo study swelling study

Journal

Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357

Informations de publication

Date de publication:
14 Oct 2021
Historique:
received: 15 09 2021
revised: 08 10 2021
accepted: 09 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Glutamic acid-co-poly(acrylic acid) (GAcPAAc) hydrogels were prepared by the free radical polymerization technique using glutamic acid (GA) as a polymer, acrylic acid (AAc) as a monomer, ethylene glycol dimethylacrylate (EGDMA) as a cross-linker, and ammonium persulfate (APS) as an initiator. Increase in gel fraction was observed with the increasing concentration of glutamic acid, acrylic acid, and ethylene glycol dimethylacrylate. High percent porosity was indicated by developed hydrogels with the increase in the concentration of glutamic acid and acrylic acid, while a decrease was seen with the increasing concentration of EGDMA, respectively. Maximum swelling and drug release was exhibited at high pH 7.4 compared to low pH 1.2 by the newly synthesized hydrogels. Similarly, both swelling and drug release increased with the increasing concentration of glutamic acid and acrylic acid and decreased with the increase in ethylene glycol dimethylacrylate concentration. The drug release was considered as non-Fickian transport and partially controlled by viscoelastic relaxation of hydrogel. In-vivo study revealed that the AUC

Identifiants

pubmed: 34685304
pii: polym13203541
doi: 10.3390/polym13203541
pmc: PMC8541255
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Science Council of Taiwan
ID : MOST 110-2320-B-037-014-MY2
Organisme : Zuoying Branch of Kaohsiung Armed Forces General Hospita
ID : KAFGH-ZY-A-1100026
Organisme : Kaohsiung Medical University Research Foundation
ID : KMU-TC109A03-1

Références

Eur J Pharm Biopharm. 2005 Apr;59(3):485-90
pubmed: 15760729
Biotechnol Prog. 2010 May-Jun;26(3):734-42
pubmed: 20063385
Pharmaceuticals (Basel). 2021 Mar 08;14(3):
pubmed: 33800248
AAPS PharmSciTech. 2007 Feb 23;8(1):14
pubmed: 17408214
Carbohydr Polym. 2018 Feb 1;181:1169-1179
pubmed: 29253946
J Mech Behav Biomed Mater. 2020 Apr;104:103696
pubmed: 32174438
Pak J Pharm Sci. 2006 Apr;19(2):119-24
pubmed: 16751122
Daru. 2015 Aug 19;23:41
pubmed: 26283081
Indian J Pharm Sci. 2009 Jul;71(4):421-7
pubmed: 20502548
Drug Dev Ind Pharm. 2021 Mar;47(3):465-476
pubmed: 33651645
Pharmaceuticals (Basel). 2021 Mar 25;14(4):
pubmed: 33806015
Pharmaceuticals (Basel). 2020 Nov 17;13(11):
pubmed: 33212866
Drug Dev Ind Pharm. 2020 Feb;46(2):272-282
pubmed: 31928342
Gels. 2021 Aug 05;7(3):
pubmed: 34449621
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:251-257
pubmed: 27524019
Mini Rev Med Chem. 2004 Feb;4(2):179-88
pubmed: 14965290
Int J Biol Macromol. 2018 Dec;120(Pt B):1624-1631
pubmed: 30287359
Life Sci. 2021 Feb 15;267:118931
pubmed: 33359243
Biomaterials. 1997 Mar;18(5):383-8
pubmed: 9061178
Gels. 2021 Jun 09;7(2):
pubmed: 34207688
Gels. 2021 Jan 27;7(1):
pubmed: 33514036
Colloids Surf B Biointerfaces. 2021 Aug;204:111819
pubmed: 33964528
Eur J Pharm Biopharm. 2007 Feb;65(2):204-14
pubmed: 16996255
Int J Biol Macromol. 2021 Aug 31;185:229-239
pubmed: 34119552
AAPS PharmSciTech. 2006 Aug 04;7(3):64
pubmed: 17025245
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110928
pubmed: 32409077
Int J Pharm. 2019 Feb 10;556:236-245
pubmed: 30553956
Int J Biol Macromol. 2019 Sep 1;136:661-667
pubmed: 31201915
Int J Pharm. 2015 Jun 20;487(1-2):110-9
pubmed: 25865571
Ther Deliv. 2019 Nov;10(11):697-717
pubmed: 31789106
Acta Biomater. 2008 May;4(3):733-44
pubmed: 18280800
J Basic Clin Pharm. 2012 Dec;4(1):2-9
pubmed: 24808662
Indian J Pharm Sci. 2015 Jan-Feb;77(1):83-90
pubmed: 25767322
Biomol Eng. 2007 Feb;24(1):131-9
pubmed: 16835016
J Colloid Interface Sci. 2006 Mar 15;295(2):393-400
pubmed: 16288772

Auteurs

Muhammad Suhail (M)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.

Chuan-Ming Shih (CM)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.

Jia-Yu Liu (JY)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.

Wan-Chu Hsieh (WC)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.

Yu-Wen Lin (YW)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.

Muhammad Usman Minhas (MU)

College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.

Pao-Chu Wu (PC)

School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan.
Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Classifications MeSH